Viewing nowCombinationBidaforte Met Tablet 50/1000 Milligrams (Vildagliptin, Metformin Hydrochloride)
Vildagliptin 50mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GENUONE Science Co., Ltd.

MFDS item code 202301838 · Approved 2023.06.14 · Insurance code 671707300
Improvement of glycemic control in type 2 diabetes mellitus
This medication is administered as a treatment combining vildagliptin and metformin to help patients with type 2 diabetes achieve more effective blood sugar control alongside dietary and exercise therapy. It stabilizes blood glucose levels, thus enhancing the therapeutic effects of diabetes treatment.
For the treatment of patients with type 2 diabetes, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding vildagliptin 100mg and metformin 2000mg. Doses of vildagliptin greater than 100mg daily are not recommended. This medicine is generally administered with food or immediately after a meal to reduce gastrointestinal adverse reactions caused by metformin. 1. Patients with no prior history of antidiabetic drug therapy who do not achieve adequate glycemic control with monotherapy: The initial dose is 1 tablet of this medicine 50/500mg once daily. The dose may be gradually increased up to 1 tablet of 50/1000mg twice daily. 2. Patients whose blood glucose is not adequately controlled with metformin monotherapy: The initial dose of this medicine is vildagliptin 100mg daily plus the current dose of metformin. The initial dose should be determined according to the patient's current treatment regimen. Take 1 tablet of this medicine 50mg/850mg or 50mg/1000mg twice daily, in the morning and evening. 3. Patients switching from combination therapy with vildagliptin and metformin: Patients switching to this medicine from combination therapy with vildagliptin and metformin may start at their current doses of vildagliptin and metformin. 4. When used in combination with a sulfonylurea or insulin: Administer vildagliptin 50mg twice daily (total daily dose 100mg) and a dose of metformin similar to the current dose. - When this medicine is used in combination with a sulfonylurea, the sulfonylurea dose may need to be reduced to reduce the risk of hypoglycemia. No studies have been conducted to evaluate the safety and efficacy of switching to this medicine from another oral antihyperglycemic agent. Any change in the treatment regimen for type 2 diabetes may lead to changes in glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. If you miss a dose of this medicine, take it with your next meal unless it is time to take the next dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended for patients with clinical or laboratory evidence of hepatic impairment, including patients whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment with this medicine.
This medication is primarily used for the treatment of diabetes and helps in controlling blood sugar levels. Caution is required when taking this medication as severe lactic acidosis or hypoglycemia may occur. It should especially be avoided by patients with moderate to severe impaired kidney function, heart failure, acute infections, or severe trauma. If a test using a radiologic iodinated contrast agent is to be conducted, this medication should be discontinued 48 hours prior to the test and resumed only after confirming normal kidney function following the test. It is safe to avoid this medication during pregnancy and lactation. People should be cautious about irregular dietary habits, vigorous exercise, and concomitant use with other medications as these may elevate risks of hypoglycemia or lactic acidosis. Regular testing of liver and kidney function should be done during treatment, and if any deterioration of liver or kidney function is observed, the doctor should be consulted immediately. This medication cannot replace insulin when used alone and should not be used by patients with type 1 diabetes or diabetic ketoacidosis. If symptoms of acute pancreatitis appear, the medication should be discontinued immediately and healthcare professionals should be informed. It is advisable to avoid excessive alcohol consumption. Hypoglycemic symptoms may occur, so sugars should be consumed when symptoms arise, and consultation with a doctor is needed if necessary. When administered to elderly patients, kidney function must be carefully monitored, and in case of overdose, immediate hospital visit for appropriate treatment is required. Use of this medication is not recommended for children and adolescents. During treatment, symptoms or adverse reactions should be consulted with a doctor immediately, especially if blisters or ulcers appear on the skin, and it is crucial to report promptly to healthcare professionals. Finally, this medication should be stored out of the reach of children and not transferred into another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its effectiveness.
Dark yellow oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationVildagliptin 50mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
GENUONE Science Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Korea United Pharm, Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ahn-Guk Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationVildagliptin 50mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
AhnGuk NewPharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.